Ida Franiak-Pietryga, PhD
University of California, San Diego
H-index: 14
North America-United States
Top articles of Ida Franiak-Pietryga, PhD
There and back again: a dendrimer’s tale
2022/9/3
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
Nature communications
2022/7/5
Neurotoxicity of poly (propylene imine) glycodendrimers
Drug and Chemical Toxicology
2022/7/4
Neoadjuvant Immunoradiotherapy in a Tobacco-Signature Preclinical Oral Squamous Cell Carcinoma Model
International Journal of Radiation Oncology, Biology, Physics
2022/4/1
Activated B cells and plasma cells are resistant to radiation therapy
International Journal of Radiation Oncology* Biology* Physics
2022/2/1
601 Sequencing immunotherapy before lymphatic ablation unleashes cDC1-dependent antitumor immunity in HNSCC
2021/11/1
All that glitters is not silver—a new look at microbiological and medical applications of silver nanoparticles
2021/1/16
Maltotriose-modified poly (propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in …
Toxicology and Applied Pharmacology
2020/9/15
Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej
2020/4/30
Anti-tumour activity of glycodendrimer nanoparticles in a subcutaneous MEC-1 xenograft model of human chronic lymphocytic leukemia
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)
2020/2/1
B cell Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Acivated by Radiation and PD-1 Blockade.
Clinical Cancer Research
2020
Co-Authors
